Clyde D. Ford

1.5k total citations
47 papers, 1.1k citations indexed

About

Clyde D. Ford is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Clyde D. Ford has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Clyde D. Ford's work include Neutropenia and Cancer Infections (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Microscopic Colitis (8 papers). Clyde D. Ford is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Microscopic Colitis (8 papers). Clyde D. Ford collaborates with scholars based in United States, Ireland and Cyprus. Clyde D. Ford's co-authors include Finn Bo Petersen, Brandon Webb, Daanish Hoda, Bert K. Lopansri, Bashar Dabbas, Johnathan M. Lancaster, Alexander Tsodikov, Charles L. Wiggins, Michael E. Carney and Kevin A. Strait and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and FEBS Letters.

In The Last Decade

Clyde D. Ford

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clyde D. Ford United States 19 343 269 268 221 174 47 1.1k
Imtiaz A. Malik Pakistan 23 1.2k 3.5× 84 0.3× 195 0.7× 54 0.2× 240 1.4× 57 1.8k
Lynya Talley United States 17 229 0.7× 172 0.6× 275 1.0× 32 0.1× 454 2.6× 24 1.3k
Rita Van Damme‐Lombaerts Belgium 23 231 0.7× 197 0.7× 208 0.8× 339 1.5× 121 0.7× 61 1.9k
B Gibson United Kingdom 27 472 1.4× 412 1.5× 348 1.3× 824 3.7× 395 2.3× 58 2.4k
Ji Yun Lee South Korea 24 708 2.1× 281 1.0× 437 1.6× 121 0.5× 321 1.8× 105 1.9k
Martin Karpinski Canada 28 298 0.9× 99 0.4× 168 0.6× 122 0.6× 400 2.3× 52 3.4k
Jae Wook Lee South Korea 18 218 0.6× 114 0.4× 202 0.8× 455 2.1× 191 1.1× 153 1.5k
Antonio Guasch United States 16 95 0.3× 548 2.0× 198 0.7× 449 2.0× 187 1.1× 24 1.7k
Raja Ramachandran India 20 62 0.2× 466 1.7× 187 0.7× 114 0.5× 264 1.5× 167 1.9k
Graziella Zacchello Italy 26 132 0.4× 125 0.5× 178 0.7× 305 1.4× 293 1.7× 79 2.1k

Countries citing papers authored by Clyde D. Ford

Since Specialization
Citations

This map shows the geographic impact of Clyde D. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clyde D. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clyde D. Ford more than expected).

Fields of papers citing papers by Clyde D. Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clyde D. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clyde D. Ford. The network helps show where Clyde D. Ford may publish in the future.

Co-authorship network of co-authors of Clyde D. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Clyde D. Ford. A scholar is included among the top collaborators of Clyde D. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clyde D. Ford. Clyde D. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ford, Clyde D., Bert K. Lopansri, Bradley D. Hunter, Julie Asch, & Daanish Hoda. (2024). Multiplexed Gastrointestinal PCR Panels for the Evaluation of Diarrhea in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 30(8). 814.e1–814.e7. 6 indexed citations
2.
Ford, Clyde D., Bert K. Lopansri, Bradley D. Hunter, et al.. (2024). Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia. Infection Control and Hospital Epidemiology. 46(1). 77–80. 1 indexed citations
3.
Hoda, Daanish, Bradley D. Hunter, Prashant K. Sharma, et al.. (2022). ESBL Producing Enterobacteriaceae (ESBLPE) Carriage on a Unit Dedicated to Hematologic Malignancies and HSCT. Transplantation and Cellular Therapy. 28(3). S379–S380. 1 indexed citations
4.
Ford, Clyde D., Bert K. Lopansri, Brandon Webb, et al.. (2018). Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. American Journal of Infection Control. 47(4). 394–399. 13 indexed citations
5.
Webb, Brandon, Michaela A. Gazdik, Bert K. Lopansri, et al.. (2017). Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation. Clinical Infectious Diseases. 64(12). 1753–1759. 35 indexed citations
6.
Ford, Clyde D., Michaela A. Gazdik, Bert K. Lopansri, et al.. (2016). Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes. Biology of Blood and Marrow Transplantation. 23(2). 340–346. 33 indexed citations
7.
Ford, Clyde D., Bert K. Lopansri, Michaela A. Gazdik, et al.. (2016). Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation. American Journal of Infection Control. 44(10). 1110–1115. 23 indexed citations
8.
Ford, Clyde D., Bert K. Lopansri, Michaela A. Gazdik, et al.. (2015). The clinical impact of vancomycin‐resistant E nterococcus colonization and bloodstream infection in patients undergoing autologous transplantation. Transplant Infectious Disease. 17(5). 688–694. 14 indexed citations
10.
Nagaya, Hiroshi, et al.. (2015). Idiopathic Interstitial Pulmonary Fibrosis. American Review of Respiratory Disease.
11.
Petersen, Finn Bo & Clyde D. Ford. (2009). Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia. Current Opinion in Oncology. 21(Suppl 1). S7–S9. 1 indexed citations
12.
Ford, Clyde D., et al.. (2006). False-Positive Restaging PET Scans Involving the Spleen in Two Patients With Aggressive Non-Hodgkin Lymphoma. Clinical Nuclear Medicine. 31(7). 391–393. 16 indexed citations
13.
Ford, Clyde D., et al.. (2004). Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplantation. 33(9). 901–905. 43 indexed citations
14.
Ford, Clyde D., et al.. (2003). An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion. 43(5). 622–625. 31 indexed citations
15.
Carney, Michael E., Johnathan M. Lancaster, Clyde D. Ford, Alexander Tsodikov, & Charles L. Wiggins. (2002). A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not?. Gynecologic Oncology. 84(1). 36–42. 167 indexed citations
16.
17.
Ford, Clyde D., et al.. (1998). Factors affecting the efficiency of collection of CD34‐positive peripheral blood cells by a blood cell separator. Transfusion. 38(11-12). 1046–1050. 45 indexed citations
18.
Ford, Clyde D., et al.. (1994). Transfusion and second malignancy. Transfusion. 34(1). 63–65. 9 indexed citations
19.
Classen, David C., et al.. (1990). Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. The American Journal of Medicine. 89(4). 441–446. 79 indexed citations
20.
Ford, Clyde D., et al.. (1983). Natural killer cells in in utero diethylstilbesterol-exposed patients. Gynecologic Oncology. 16(3). 400–404. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026